Related Experiment Videos
Genetically confirmed clinical Huntington's disease with no observable cell loss
M Caramins1, G Halliday, E McCusker
1Department of Molecular and Clinical Genetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. melody.caramins@email.cs.nsw.gov.au
Journal of Neurology, Neurosurgery, and Psychiatry
|June 18, 2003
Summary
This study details a rare case of Huntington's disease (HD) with confirmed genetic mutation but atypical neuropathology. The findings highlight the importance of genetic testing in diagnosing HD, even with unusual brain changes.
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- Huntington's disease (HD) is a neurodegenerative disorder typically affecting the neostriatum.
- Genetic cause is an expanded CAG triplet repeat within the IT15 gene on chromosome 4.
- Limited neuropathology in clinically diagnosed HD cases is rare, with few genetically confirmed instances.
Observation:
- A patient presented with aggressive behavior and memory loss, clinically suspected of HD despite no family history.
- Genetic testing confirmed the HD mutation (CAG repeat expansion).
- Clinical progression was rapid, leading to death within three years.
Findings:
- Neuropathological examination revealed a largely intact neostriatum.
- Unexpected findings included bilateral ischemic damage and cell loss in the external globus pallidus.
- This localized pathology could account for the observed clinical symptoms of HD.
Implications:
- This case is only the second report of genetically confirmed, clinically manifest HD with minimal HD-specific neuropathology.
- The findings suggest potential for misdiagnosis at post-mortem if relying solely on typical neostriatal degeneration.
- Understanding atypical presentations is crucial for accurate diagnosis and genetic counseling for affected families.